QualityStocksNewsBreaks – Zacks Small Cap Research Issues Update, Maintains Price Target on Pressure BioSciences Inc. (PBIO)
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform-technology solutions to the life sciences and other industries, was recently covered in a research report by Zacks Small Cap Research, a division of Zacks Investment Research. Among other highlights, Zacks maintained its $4.44 share price target on shares of PBIO. An article discussing the company reads, “The Zacks report (http://ibn.fm/z1W3H) points to demand that ‘is expected to accelerate starting in 2020,’ which nonetheless follows many years of consistent yearly revenue increases by PBIO. The company itself is standing by its stated…